By a News Reporter-Staff News Editor at Life Science Weekly — According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Avalanche Biotechnologies, Inc. (Form S-1) was posted on June 30, 2014.
The SIC code for this company is 2836, Biological Products, (No Diagnostic Substances).
There were 44 documents filed with this form. The SEC file number is 0001193125-14-255970.
The contact information for this company is 2749 CAROLINA AVENUE, REDWOOD CITY CA 94061, 415-203-1722.
Our editors provided additional information about Form S-1: This is the basic registration form. It can be used to register securities for which no other form is authorized or prescribed, except securities of foreign governments or political sub-divisions thereof.
A U.S. Securities and Exchange Commission filing is a formal document or financial statement submitted to the SEC by publicly-traded companies.
For additional information on this SEC filing see: http://www.sec.gov/Archives/edgar/data/1501756/0001193125-14-255970-index.html.
Keywords for this news article include: SEC Filing, Biological Products, (No Diagnostic Substances), Avalanche Biotechnologies Inc..
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC
